Income Statement Kanadevia Corporation

Equities

7004

JP3789000001

Industrial Machinery & Equipment

Market Closed - Japan Exchange Other stock markets 02:30:00 2026-05-08 am EDT			5-day change	1st Jan Change
1,275.00 ^JPY	+2.49%		+6.25%	+34.21%

Mar. 26	Kitz To Acquire V Tex To Expand Semiconductor Business	MT
Mar. 17	Oriental Shiraishi Corporation Revises Earnings Guidance for the Year Ending March 31, 2026	CI

f4601106d2a296c3.D25qm5DSc3Cb8KRwKvLq2K6NJW7rrnlQr3rH5VtBZJw.dS0PwtWQNRv4yN4UQ8StlOrJVAjdnjYRnhD0nysvLq1KHyv_9eIfEs2llA

Published financial data: KANADEVIA CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	409B	442B	493B	556B	611B
Total Revenues	409B	442B	493B	556B	611B
Cost of Goods Sold, Total	336B	370B	409B	461B	496B
Gross Profit	72.82B	72.15B	83.36B	95.3B	114B
Selling General & Admin Expenses, Total	50.75B	50.47B	54.72B	59.73B	75.21B
R&D Expenses	6.66B	6.14B	8.58B	11.25B	12.03B
Other Operating Expenses, Total	57.42B	56.61B	63.3B	70.98B	87.24B
Operating Income	15.4B	15.54B	20.06B	24.32B	26.95B
Interest Expense, Total	-738M	-809M	-788M	-854M	-817M
Interest And Investment Income	398M	182M	455M	975M	1.08B
Net Interest Expenses	-340M	-627M	-333M	121M	267M
Income (Loss) On Equity Invest.	-622M	260M	423M	1.69B	645M
Currency Exchange Gains (Loss)	269M	-935M	-128M	1.28B	477M
Other Non Operating Income (Expenses)	-2.97B	-2.74B	-2.19B	-1.76B	-2.78B
EBT, Excl. Unusual Items	11.73B	11.5B	17.83B	25.64B	25.56B
Gain (Loss) On Sale Of Investments	60M	4.07B	1.43B	-	-1.23B
Gain (Loss) On Sale Of Assets	-	-	1.02B	-	-
Asset Writedown	-4.92B	-3.69B	-2.14B	-448M	-
Other Unusual Items	-	-	381M	-1.12B	-651M
EBT, Incl. Unusual Items	6.87B	11.87B	18.52B	24.08B	23.68B
Income Tax Expense	2.58B	3.96B	2.91B	5B	1.39B
Earnings From Continuing Operations	4.29B	7.91B	15.62B	19.08B	22.29B
Net Income to Company	4.29B	7.91B	15.62B	19.08B	22.29B
Minority Interest	-33M	-13M	-38M	-80M	-188M
Net Income - (IS)	4.26B	7.9B	15.58B	19B	22.1B
Net Income to Common Incl Extra Items	4.26B	7.9B	15.58B	19B	22.1B
Net Income to Common Excl. Extra Items	4.26B	7.9B	15.58B	19B	22.1B
Per Share Items
Net EPS - Basic	25.26	46.87	92.43	112.74	131.33
Basic EPS - Continuing Operations	25.26	46.87	92.43	112.74	131.33
Basic Weighted Average Shares Outstanding	169M	169M	169M	169M	168M
Net EPS - Diluted	25.26	46.87	92.43	112.74	131.33
Diluted EPS - Continuing Operations	25.26	46.87	92.43	112.74	131.33
Diluted Weighted Average Shares Outstanding	169M	169M	169M	169M	168M
Normalized Basic EPS	43.31	42.56	65.91	94.63	93.81
Normalized Diluted EPS	43.31	42.56	65.91	94.63	93.81
Dividend Per Share	12	12	18	23	25
Payout Ratio	47.49	25.6	12.98	15.96	17.54
Supplemental Items
EBITDA	26.2B	26.46B	31.03B	35.81B	40.31B
EBITA	15.96B	15.8B	20.52B	24.67B	28.4B
EBIT	15.4B	15.54B	20.06B	24.32B	26.95B
EBITDAR	28.53B	28.74B	33.32B	38.74B	43.14B
Effective Tax Rate - (Ratio)	37.51	33.36	15.71	20.77	5.85
Normalized Net Income	7.3B	7.17B	11.11B	15.95B	15.79B
Non-Cash Pension Expense	1.02B	26M	-623M	-1.81B	-1.82B
Supplemental Operating Expense Items
Selling and Marketing Expenses	6.62B	7.12B	7.61B	7.39B	7.76B
Research And Development Expense From Footnotes	6.66B	6.14B	8.58B	11.25B	12.03B
Net Rental Expense, Total	2.33B	2.27B	2.29B	2.93B	2.83B
Imputed Operating Lease Interest Expense	139M	155M	162M	225M	163M
Imputed Operating Lease Depreciation	2.19B	2.12B	2.13B	2.71B	2.67B

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	47.28B	67.2B	86.4B	71.6B	70.76B
Short Term Investments	-	-	-	-	1M
Total Cash And Short Term Investments	47.28B	67.2B	86.4B	71.6B	70.76B
Accounts Receivable, Total	166B	187B	195B	234B	227B
Total Receivables	166B	187B	195B	234B	227B
Inventory	23.95B	14.47B	17.18B	19.9B	23.08B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	22.26B	24.05B	20.75B	21.81B	36.14B
Total Current Assets	260B	292B	319B	347B	357B
Net Property Plant And Equipment	113B	111B	98.25B	104B	136B
Long-term Investments	29.82B	29.84B	32B	44.14B	50.28B
Goodwill	1.63B	1.49B	1.08B	4.26B	14.06B
Other Intangibles, Total	7.87B	9.96B	10.05B	15B	27.16B
Loans Receivable Long-Term	28M	27M	25M	889M	3.63B
Deferred Tax Assets Long-Term	17.09B	16.96B	19.36B	17.71B	21.34B
Deferred Charges Long-Term	62M	93M	67M	41M	20M
Other Long-Term Assets, Total	3M	2M	3M	2M	2M
Total Assets	429B	461B	480B	534B	610B
Liabilities
Accounts Payable, Total	63.38B	71.81B	73.28B	57.93B	65.82B
Accrued Expenses, Total	59.03B	71.03B	70.14B	84.08B	81.8B
Short-term Borrowings	14.57B	26.72B	16.62B	19.59B	36.4B
Current Portion of Long-Term Debt	5B	-	-	10B	10B
Current Portion of Leases	1.01B	1.3B	1.34B	1.75B	1.66B
Current Income Taxes Payable	1.11B	4.08B	4.02B	2.68B	4.97B
Other Current Liabilities	54.01B	63.08B	75.41B	97.65B	93.63B
Total Current Liabilities	198B	238B	241B	274B	294B
Long-Term Debt	74.53B	61.18B	65.88B	54.44B	80.13B
Long-Term Leases	3.04B	2.69B	2.63B	5.66B	7.57B
Pension & Other Post Retirement Benefits	20.94B	21.95B	21.42B	21.04B	16.5B
Deferred Tax Liability Non Current	527M	428M	415M	449M	5.82B
Other Non Current Liabilities	4.02B	3.98B	7.22B	9.37B	7.47B
Total Liabilities	301B	328B	338B	365B	412B
Common Stock, Total	45.44B	45.44B	45.44B	45.44B	45.44B
Additional Paid In Capital	8.53B	8.53B	8.18B	7.8B	7.8B
Retained Earnings	67.3B	71.16B	84.68B	101B	119B
Treasury Stock	-1.02B	-1.03B	-1.03B	-1.03B	-1.33B
Comprehensive Income and Other	6.08B	7.19B	2.34B	9.79B	18.58B
Total Common Equity	126B	131B	140B	163B	189B
Minority Interest	1.84B	1.63B	1.69B	6.29B	8.53B
Total Equity	128B	133B	141B	169B	198B
Total Liabilities And Equity	429B	461B	480B	534B	610B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	169M	169M	169M	169M	168M
ECS Total Common Shares Outstanding	169M	169M	169M	169M	168M
Book Value / Share	749.57	779.08	828.46	965.2	1.13K
Tangible Book Value	117B	120B	128B	143B	148B
Tangible Book Value Per Share	693.2	711.13	762.44	850.92	880.83
Total Debt	98.15B	91.88B	86.46B	91.44B	136B
Net Debt	50.87B	24.68B	61M	19.84B	65B
Debt Equivalent of Unfunded Proj. Benefit Obligation	15.98B	11.64B	5.77B	3.41B	276M
Debt Equivalent Oper. Leases	18.62B	18.18B	18.3B	23.47B	22.64B
Minority Interest, Total (Incl. Fin. Div)	1.84B	1.63B	1.69B	6.29B	8.53B
Inventories - Raw Materials, Total	5.59B	6.52B	8.33B	10.57B	12.77B
Inventories - Work In Process, Total	16.74B	6.84B	7.39B	7.04B	8.26B
Inventories - Finished Goods, Total	1.62B	1.12B	1.46B	2.3B	2.05B
Full Time Employees	11.09K	11.54K	11.4K	12.15K	12.96K
Accumulated Allowance for Doubtful Accounts (Supple)	3.31B	3.26B	3.86B	1.05B	889M
Order Backlog	764B	1,018B	1,318B	1,543B	1,796B

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	6.87B	11.87B	18.53B	24.08B	23.68B
Depreciation & Amortization - CF	10.24B	10.66B	10.52B	11.13B	11.91B
Amortization of Goodwill and Intangible Assets - (CF)	563M	258M	458M	350M	1.45B
Depreciation & Amortization, Total	10.8B	10.92B	10.97B	11.48B	13.37B
(Gain) Loss From Sale Of Asset	4.78B	3.69B	1.12B	448M	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-1.43B	-	1.23B
(Income) Loss On Equity Investments - (CF)	622M	-260M	-423M	-1.69B	-645M
Other Operating Activities, Total	-3.3B	-4.15B	-2.43B	-5.3B	-2.05B
Change In Accounts Receivable	-8.34B	-13.73B	-7.54B	-27.64B	15.76B
Change In Inventories	-315M	10.74B	-3.77B	-802M	-647M
Change In Accounts Payable	8.5B	9.01B	-2.1B	-9.54B	697M
Change in Other Net Operating Assets	3.05B	-1.24B	15.08B	9.44B	-26.63B
Cash from Operations	22.68B	26.86B	28.01B	478M	24.77B
Capital Expenditure	-10.51B	-7.47B	-6.57B	-7.77B	-25.18B
Sale of Property, Plant, and Equipment	372M	302M	3.28B	250M	223M
Cash Acquisitions	-2.51B	7.73B	-3.11B	-3.47B	-25.06B
Divestitures	127M	2.51B	5.29B	1.08B	-15M
Sale (Purchase) of Intangible assets	-1.42B	-1.76B	-2.07B	-4.33B	-3.25B
Investment in Marketable and Equity Securities, Total	224M	-452M	626M	-344M	-2.88B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-829M	-2.52B
Other Investing Activities, Total	-130M	85M	97M	-6.08B	2.1B
Cash from Investing	-13.85B	943M	-2.46B	-21.49B	-56.57B
Short Term Debt Issued, Total	856M	-	1.34B	4.32B	23.39B
Long-Term Debt Issued, Total	1.75B	11.24B	20.66B	9.87B	34.36B
Total Debt Issued	2.6B	11.24B	22.01B	14.19B	57.74B
Short Term Debt Repaid, Total	-	-7.66B	-	-	-
Long-Term Debt Repaid, Total	-5.33B	-9.35B	-26.64B	-13.29B	-22.63B
Total Debt Repaid	-5.33B	-17.01B	-26.64B	-13.29B	-22.63B
Common Dividends Paid	-2.02B	-2.02B	-2.02B	-3.03B	-3.88B
Common & Preferred Stock Dividends Paid	-2.02B	-2.02B	-2.02B	-3.03B	-3.88B
Other Financing Activities, Total	-523M	-964M	-1.18B	-472M	-1.09B
Cash from Financing	-5.27B	-8.76B	-7.84B	-2.61B	30.15B
Foreign Exchange Rate Adjustments	655M	1.1B	1.21B	5.02B	584M
Miscellaneous Cash Flow Adjustments	-1M	3M	-	3.5B	3M
Net Change in Cash	4.22B	20.14B	18.92B	-15.1B	-1.07B
Supplemental Items
Cash Interest Paid	607M	820M	788M	883M	429M
Cash Income Tax Paid (Refund)	3.64B	4.21B	4.12B	5.56B	2.9B
Levered Free Cash Flow	9.36B	30.55B	19.82B	-9.47B	-5.74B
Unlevered Free Cash Flow	9.82B	31.05B	20.31B	-8.94B	-5.23B
Change In Net Working Capital	-1.32B	-19.65B	-5.45B	23.53B	7B
Net Debt Issued / Repaid	-2.73B	-5.77B	-4.63B	899M	35.12B

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	2.29	2.18	2.66	3	2.95
Return on Total Capital	4.32	4.31	5.54	6.23	5.67
Return On Equity %	3.47	6.06	11.39	12.3	12.15
Return on Common Equity	3.49	6.13	11.5	12.57	12.56
Margin Analysis
Gross Profit Margin %	17.82	16.33	16.92	17.15	18.7
SG&A Margin	12.42	11.42	11.11	10.75	12.32
EBITDA Margin %	6.41	5.99	6.3	6.44	6.6
EBITA Margin %	3.91	3.58	4.16	4.44	4.65
EBIT Margin %	3.77	3.52	4.07	4.38	4.41
Income From Continuing Operations Margin %	1.05	1.79	3.17	3.43	3.65
Net Income Margin %	1.04	1.79	3.16	3.42	3.62
Net Avail. For Common Margin %	1.04	1.79	3.16	3.42	3.62
Normalized Net Income Margin	1.79	1.62	2.25	2.87	2.59
Levered Free Cash Flow Margin	2.29	6.91	4.02	-1.7	-0.94
Unlevered Free Cash Flow Margin	2.4	7.03	4.12	-1.61	-0.86
Asset Turnover
Asset Turnover	0.97	0.99	1.05	1.1	1.07
Fixed Assets Turnover	3.59	3.95	4.72	5.48	5.08
Receivables Turnover (Average Receivables)	2.53	2.51	2.59	2.6	2.65
Inventory Turnover (Average Inventory)	14.19	19.24	25.86	24.84	23.09
Short Term Liquidity
Current Ratio	1.31	1.23	1.32	1.27	1.21
Quick Ratio	1.08	1.07	1.17	1.12	1.01
Operating Cash Flow to Current Liabilities	0.11	0.11	0.12	0	0.08
Days Sales Outstanding (Average Receivables)	144.11	145.62	141.14	141	137.77
Days Outstanding Inventory (Average Inventory)	25.73	18.97	14.11	14.74	15.81
Average Days Payable Outstanding	70.13	68.51	64.26	51.83	45.21
Cash Conversion Cycle (Average Days)	99.71	96.09	90.99	103.9	108.36
Long Term Solvency
Total Debt/Equity	76.58	69.12	61.19	54.12	68.6
Total Debt / Total Capital	43.37	40.87	37.96	35.12	40.69
LT Debt/Equity	60.52	48.04	48.48	35.58	44.32
Long-Term Debt / Total Capital	34.28	28.41	30.08	23.08	26.29
Total Liabilities / Total Assets	70.15	71.18	70.54	68.34	67.54
EBIT / Interest Expense	20.86	19.21	25.45	28.48	32.98
EBITDA / Interest Expense	35.5	32.71	39.38	41.93	49.34
(EBITDA - Capex) / Interest Expense	21.26	23.47	31.04	32.83	18.52
Total Debt / EBITDA	3.75	3.47	2.79	2.55	3.37
Net Debt / EBITDA	1.94	0.93	0	0.55	1.61
Total Debt / (EBITDA - Capex)	6.26	4.84	3.54	3.26	8.97
Net Debt / (EBITDA - Capex)	3.24	1.3	0	0.71	4.3
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	1.53	8.13	11.52	12.82	9.84
Gross Profit, 1 Yr. Growth %	5.1	-0.91	15.54	14.33	19.82
EBITDA, 1 Yr. Growth %	6.62	1	17.26	15.4	12.58
EBITA, 1 Yr. Growth %	10.18	-1	29.84	20.27	15.1
EBIT, 1 Yr. Growth %	10.83	0.94	29.05	21.27	10.78
Earnings From Cont. Operations, 1 Yr. Growth %	91.48	84.39	97.36	22.18	16.84
Net Income, 1 Yr. Growth %	93.81	85.51	97.2	21.97	16.34
Normalized Net Income, 1 Yr. Growth %	31.44	-1.73	54.86	43.57	-1
Diluted EPS Before Extra, 1 Yr. Growth %	93.81	85.52	97.21	21.97	16.49
Accounts Receivable, 1 Yr. Growth %	5.99	12.36	4.29	20.17	-2.83
Inventory, 1 Yr. Growth %	2.42	-39.58	18.73	15.83	15.97
Net Property, Plant and Equip., 1 Yr. Growth %	-0.84	-2.46	-11.11	6.34	30.23
Total Assets, 1 Yr. Growth %	4.84	7.41	4.02	11.24	14.26
Tangible Book Value, 1 Yr. Growth %	8.57	2.58	7.21	11.6	3.31
Common Equity, 1 Yr. Growth %	7.06	3.93	6.34	16.5	16.42
Cash From Operations, 1 Yr. Growth %	-30.87	18.42	4.28	-98.29	5.08K
Capital Expenditures, 1 Yr. Growth %	4.94	-28.89	-12.04	18.19	224.08
Levered Free Cash Flow, 1 Yr. Growth %	-67.46	226.4	-35.11	-147.8	-39.44
Unlevered Free Cash Flow, 1 Yr. Growth %	-66.47	216.22	-34.58	-144.01	-41.53
Dividend Per Share, 1 Yr. Growth %	0	0	50	27.78	8.7
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	3.95	4.77	9.81	12.17	11.32
Gross Profit, 2 Yr. CAGR %	9.16	2.05	6.99	14.93	17.04
EBITDA, 2 Yr. CAGR %	24.41	3.77	8.83	16.32	13.98
EBITA, 2 Yr. CAGR %	41.36	4.44	13.38	24.97	17.66
EBIT, 2 Yr. CAGR %	44.65	5.77	14.13	25.1	15.91
Earnings From Cont. Operations, 2 Yr. CAGR %	-10.77	87.9	90.76	55.29	19.48
Net Income, 2 Yr. CAGR %	-11.57	89.61	91.27	55.09	19.12
Normalized Net Income, 2 Yr. CAGR %	41.16	13.65	23.36	49.11	19.22
Diluted EPS Before Extra, 2 Yr. CAGR %	-11.57	89.62	91.27	55.09	19.2
Accounts Receivable, 2 Yr. CAGR %	-0.87	9.12	8.25	11.95	8.06
Inventory, 2 Yr. CAGR %	-11.82	-21.33	-15.3	17.27	15.9
Net Property, Plant and Equip., 2 Yr. CAGR %	-2.16	-1.65	-6.89	-2.78	17.68
Total Assets, 2 Yr. CAGR %	0.03	6.12	5.7	7.57	12.74
Tangible Book Value, 2 Yr. CAGR %	4.04	5.53	4.87	9.38	7.38
Common Equity, 2 Yr. CAGR %	2.83	5.48	5.13	11.3	16.46
Cash From Operations, 2 Yr. CAGR %	104.41	-9.52	11.13	-86.66	-5.96
Capital Expenditures, 2 Yr. CAGR %	22.85	-13.62	-20.92	1.96	95.71
Levered Free Cash Flow, 2 Yr. CAGR %	5.92	3.07	45.53	-44.31	-46.2
Unlevered Free Cash Flow, 2 Yr. CAGR %	12.19	2.97	43.83	-46.34	-49.27
Dividend Per Share, 2 Yr. CAGR %	0	0	22.47	38.44	17.85
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	2.77	5.32	6.98	10.8	11.38
Gross Profit, 3 Yr. CAGR %	6.87	5.7	6.36	9.39	16.54
EBITDA, 3 Yr. CAGR %	18.74	16.06	8.08	10.97	15.06
EBITA, 3 Yr. CAGR %	34.67	25.53	12.3	15.63	21.59
EBIT, 3 Yr. CAGR %	37.61	28.3	13.02	16.47	20.13
Earnings From Cont. Operations, 3 Yr. CAGR %	26.8	13.66	91	64.44	41.24
Net Income, 3 Yr. CAGR %	25.17	13.2	92.11	64.63	40.92
Normalized Net Income, 3 Yr. CAGR %	54.52	25.11	26	29.76	30.08
Diluted EPS Before Extra, 3 Yr. CAGR %	25.18	13.21	92.12	64.63	40.98
Accounts Receivable, 3 Yr. CAGR %	4.68	3.36	7.49	12.08	6.79
Inventory, 3 Yr. CAGR %	-6.27	-22.26	-9.76	-5.99	16.83
Net Property, Plant and Equip., 3 Yr. CAGR %	-1.41	-2.26	-4.91	-2.67	7.17
Total Assets, 3 Yr. CAGR %	3.09	2.44	5.41	7.52	9.75
Tangible Book Value, 3 Yr. CAGR %	3.29	3.55	6.09	7.07	7.32
Common Equity, 3 Yr. CAGR %	2.62	3.19	5.77	8.79	12.98
Cash From Operations, 3 Yr. CAGR %	88.74	70.4	-5.14	-72.38	-2.66
Capital Expenditures, 3 Yr. CAGR %	1.49	2.38	-13.1	-9.58	49.91
Levered Free Cash Flow, 3 Yr. CAGR %	-9.95	54.14	-11.67	0.41	-42.73
Unlevered Free Cash Flow, 3 Yr. CAGR %	-7.12	58.48	-11.48	-3.08	-44.79
Dividend Per Share, 3 Yr. CAGR %	0	0	14.47	24.22	27.72
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	1.09	2.04	5.53	8.01	8.69
Gross Profit, 5 Yr. CAGR %	2.53	2.11	6.92	9.3	10.51
EBITDA, 5 Yr. CAGR %	1.47	2.05	14.67	16.17	10.41
EBITA, 5 Yr. CAGR %	0.04	0.55	25.71	25.31	14.41
EBIT, 5 Yr. CAGR %	0.37	0.78	27.69	27.01	14.17
Earnings From Cont. Operations, 5 Yr. CAGR %	-9.06	4.48	49.3	28.77	58.32
Net Income, 5 Yr. CAGR %	-6.15	6.14	48.31	28.39	58.68
Normalized Net Income, 5 Yr. CAGR %	2.61	2.43	41.21	34.21	23.24
Diluted EPS Before Extra, 5 Yr. CAGR %	-6.29	6.14	48.31	28.4	58.73
Accounts Receivable, 5 Yr. CAGR %	4.09	7.42	6.09	6.71	7.72
Inventory, 5 Yr. CAGR %	-5.01	-12.76	-9.99	-8.37	-0.26
Net Property, Plant and Equip., 5 Yr. CAGR %	-1.11	-1.45	-3.64	-2.47	3.55
Total Assets, 5 Yr. CAGR %	1.34	3.23	4.13	4.46	8.28
Tangible Book Value, 5 Yr. CAGR %	1.88	2.4	3.92	5.85	6.6
Common Equity, 5 Yr. CAGR %	2.05	2.56	3.62	6.36	9.92
Cash From Operations, 5 Yr. CAGR %	22.72	9.19	52.7	-38.49	-5.47
Capital Expenditures, 5 Yr. CAGR %	4.97	-1.45	-8.15	2.21	20.25
Levered Free Cash Flow, 5 Yr. CAGR %	32.53	20.89	9.11	2.58	-27.56
Unlevered Free Cash Flow, 5 Yr. CAGR %	42.53	20.29	10.63	2.76	-29.15
Dividend Per Share, 5 Yr. CAGR %	0	0	8.45	13.9	15.81